DanielBRothMD
Ophthalmology • Lakewood, NJRetinal Disease, Uveitis
Clinical Professor of Ophthalmology at Rutgers Robert Wood Johnson Medical School
Dr. Roth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 NJ-70 W
Suite 600
Lakewood, NJ 08701Phone+1 732-363-2396Fax+1 732-363-0403
Education & Training
Cleveland Clinic FoundationFellowship, Surgical Retina and Vitreous, 1998 - 2000
University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 1995 - 1998
University of TennesseeInternship, Internal Medicine, 1994 - 1995
Yale School of MedicineClass of 1994
Certifications & Licensure
NJ State Medical License 2000 - 2025
OH State Medical License 1998 - 2002
FL State Medical License 1996 - 2000- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Antenatal Vitamin D3 Supplementation in Bangladesh: Randomized Controlled Trial Start of enrollment: 2010 Aug 01
- Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients. Start of enrollment: 2013 Dec 01
- Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 2 citationsThe 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: Intraocular Pressure-Related Effects over 36 Months.Daniel B Roth, David Eichenbaum, Deepika Malik, Nathan M Radcliffe, Antonio Cutino
Ophthalmology. Retina. 2024-01-01 - Corrigendum to "The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema" [Am J Ophthalmol 2023;248;16-23].Pauline T Merrill, Nancy Holekamp, Daniel Roth, Jonathan Kasper, Ruben Grigorian
American Journal of Ophthalmology. 2023-08-01 - 4 citationsThe 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema.Pauline T Merrill, Nancy Holekamp, Daniel Roth, Jonathan Kasper, Ruben Grigorian
American Journal of Ophthalmology. 2023-04-01
Press Mentions
Prism Vision Group’s Physicians Reviewed and Approved as NJ Top Docs for 2021June 3rd, 2021
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
